tirzepatide off the market FDA says the Zepbound shortage is over. That's rattling the weight loss industry Eli Lilly cuts price of
Description
Most people who lose weight on GLP-1 medications regain it after stopping, making long-term use a realistic option for many

Analysts said upcoming data on Pfizer's obesity pill, danuglipron, will be crucial to how competitive the company can be against Eli Lilly and Novo Nordisk.

The drugs can also reduce the effectiveness of some forms of birth control, making unplanned pregnancies more likely.

Trial Registration Clinicaltrials.gov: NCT02607865 (PIONEER 3), NCT02863419 (PIONEER 4), NCT02827708 (PIONEER 5), NCT02849080 (PIONEER 7) and NCT03021187 (PIONEER 8)

Four findings that matter for how we understand health this week.

Is it OK to take tirzepatide a day early
